
The Patients Clinical Trials Leave Out - and the Evidence That Counts Them In
Episode 53
Ashish Rishi on The Patients Clinical Trials Leave Out — and the Evidence That Counts Them In | Pharma Prescribed Ashish Rishi is Founder and CEO of Unwritten Health, the Manchester-based patient experience data platform working to make life science's evidence reflect the people it's meant to serve. His mission is unsentimental — and it starts with his father. At 17, Ash watched his dad spend three years fighting for a GP referral for worsening back and bone pain. The eventual diagnosis was terminal prostate cancer, delivered to an 18-year-old and his mother — for whom English is a fourth language — in a two-minute conversation and a flyer, with no family network to turn to. His father lived six more years and passed away three months before Ash's graduation. That experience became a company. In this episode Ash explains "inclusion debt" — his term for how bias compounds at every stage of drug development: unmet need defined without the real patient voice, multi-billion-pound programmes built on focus groups of eight to ten patient experts, recruitment budgets thrown at social ads that reach the already-reachable, and value dossiers that carry only the majority narrative. By market access, it's too late to fix.
Publisher
Adam Walker’s Pharma Prescribed Podcast
Link
pharmaprescribed.podbean.com/e/the-patients-clinical-trials-leave-out-and-the-evidence-that-counts-them-in/
Published
August 15, 2026
Duration
32 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Adam Walker
Adam Walker’s Pharma Prescribed Podcast
@adamwalkerspharmaprescribedp
#patientsclinicaltrials #evidence #counts #lifesciences #management
